Iniciativa de empresário brasileiro cria chance de cura para um tipo raro de câncer
The most important business and economics newspaper in Brazil, Valor Econômico, highlights how science, data, and international collaboration can shorten pathways, accelerate diagnoses, and create real impact for patients, especially in critical areas such as rare diseases and pediatric cancer. In this interview, Dr. Packer and Fernando show how connected science expands access, improves decision-making, […]
A Medulloblastoma Initiative acelera pesquisas para ajudar crianças com câncer
Brazilian businessman Fernando Goldzstein’s quest for his son’s brain cancer cure Sparked a Global Movement to reduce the diagnostic odyssey toward rare disease diagnoses. In the rare disease realm, the term “diagnostic odyssey” refers to the long, difficult process required to confirm a patient’s illness. Families must then endure the even more excruciating path to […]
Pai corre contra o tempo para salvar seu filho adolescente e milhares de outras crianças com o mesmo tumor cerebral raro
People Magazine, one of the most prestigious international magazines, highlighted the story of the Medulloblastoma Initiative (MBI). The article shows how a personal experience gave rise to a global initiative dedicated to shortening the diagnostic odyssey and accelerating research for pediatric brain cancer. Read the full story – clicking here. Originally published in: People Magazine.
MIT Sloan reconhece a MBI entre as principais histórias de ex-alunos de 2025
Each year, the MIT Sloan School of Management highlights alumni whose work is helping shape a better future. In its Top Alumni Stories of 2025, the school recognized leaders across science, education, and global innovation. This year, MBI was honored to see our work ranked among the top alumni stories of 2025. You can read […]
Reconhecimento nacional por uma missão global.
Veja Saúde, one of Brazil’s leading publications in science and medical reporting, published a special feature this week highlighting the progress of the Medulloblastoma Initiative (MBI) and the beginning of a new phase for clinical trials in the country. In the article, experts emphasize the scientific and social impact of bringing experimental therapies for pediatric […]
O portal VivaBem / UOL destacou a trajetória da Medulloblastoma Initiative (MBI).
The article highlights the journey of Fernando Goldsztein and his son Frederico, a personal experience that led to the creation of an initiative that now brings together scientists, families, and institutions in a global effort to develop new therapies for medulloblastoma, a rare and aggressive pediatric brain tumor. By sharing the origins of the MBI, […]
Um acordo poderoso por um impacto global
On November 5th, the Medulloblastoma Initiative (MBI) and Einstein Hospital Israelita signed a scientific agreement to accelerate research and treatment for pediatric brain tumors. Founded in 1955 by São Paulo’s Jewish community, Einstein Hospital Israelita is a leading reference in healthcare, research, and social responsibility. Guided by the principles of Tikun (Transformation), Chinuch (Education), Refuá […]
MBI no The Lead in Peds
Dr. Roger Packer, Senior Director of the Center for Neuroscience and Behavioral Medicine at Children’s National Hospital (USA), joined the The Lead in Peds podcast on September 24 to discuss recent advances in therapies for pediatric brain tumors. In the episode “Breaking Barriers: Emerging Therapies in Pediatric Brain Tumors,” Dr. Packer addressed the challenges of […]
MBI inova mais uma vez e faz parceria inédita com o Einstein Hospital Israelita
The Medulloblastoma Initiative (MBI) announces a new partnership with Einstein Hospital Israelita, a collaboration that brings together two leading institutions in science and innovation with a shared purpose: to accelerate progress in the research and treatment of pediatric brain tumors. Recognized for its excellence in care, education, research, and social responsibility, Einstein combines tradition and […]
MBI mencionada pela Exame
One of the most respected magazines in the country mentioned MBI in a report about scientific advances in the treatment of medulloblastoma. With more than 50 years of history, Exame is a national reference in economic, scientific, and innovation journalism. Since 2020, it has been part of the BTG Pactual Group, consolidating itself as one […]